Therapeutic effect of an immunosupp-ressive agent, mizoribine in patients with the progression of renal failure in diabetic nephropathy
Not Applicable
- Conditions
- Diabetic nephropathy
- Registration Number
- JPRN-UMIN000001824
- Lead Sponsor
- Okayama University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who is received cortico- steroid or immunosuppressant.Patients whose blood pressure is over 160/100mmHg or whose HbA1c is over 10.0%.Patients with a hypersensitivity to MZR.Patients whose WBC are under 3000/mm3.Pregnant or nursing women.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method